Head of Biogen's copycat drug unit leaves to join Scangos startup
August 28, 2017 at 10:17 AM EDT
Alpna Seth is joining a familiar face at San Francisco-based Vir Biotechnology, which is developing treatments for infectious diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|